Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy
Published version of a preprint
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Duchenne muscular dystrophy (DMD) is caused by DMD mutations leading to dystrophin loss. Full‐length Dp427 is the primary dystrophin isoform expressed in muscle and is also expressed in the central nervous system (CNS). Two shorter isoforms, Dp140 and Dp71, are highly expressed in the CNS. While a role for Dp140 and Dp71 on DMD CNS comorbidities is well known, relationships between mutations expected to disrupt Dp140 and Dp71 and motor outcomes are not. Methods: Functional outcome data from 387 DMD boys aged 4–15 years were subdivided by DMD mutation expected effects on dystrophin isoform expression; Group 1 (Dp427 absent, Dp140/Dp71 present, n = 201); Group 2 (Dp427/Dp140 absent, Dp71 present, n = 152); and Group 3 (Dp427/Dp140/Dp71 absent, n = 34). Relationships between isoform group and North Star ambulatory assessment (NSAA) scores, 10 m walk/run velocities and rise time velocities were explored using regression analysis. Western blot analysis was used to study Dp427, Dp140 and Dp71 production in myogenic cells (control and DMD human), control skeletal muscle, DMD skeletal muscle from the three isoform groups and cerebral cortex from mice (wild‐type and DMD models). Grip strength and rotarod running test were studied in wild‐type mice and DMD mouse models. DMD mouse models were mdx (Dp427 absent, Dp140/Dp71 present), mdx52 (Dp427/Dp140 absent, Dp71 present) and DMD‐null (lacking all isoforms). Results: In DMD boys, mean NSAA scores at 5 years of age were 6.1 points lower in Group 3 than Group 1 ( P < 0.01) and 4.9 points lower in Group 3 than Group 2 ( P = 0.05). Mean peak NSAA scores were 4.0 points lower in Group 3 than Group 1 ( P < 0.01) and 1.6 points lower in Group 2 than Group 1 ( P = 0.04). Mean four‐limb grip strength was 1.5 g/g lower in mdx52 than mdx mice ( P = 0.003) and 1.5 g/g lower in DMD‐null than mdx mice ( P = 0.002). Dp71 was produced in myogenic cells (control and DMD human) and skeletal muscle from humans in Groups 1 and 2 and mdx mice, but not skeletal muscle from human controls, myogenic cells and skeletal muscle from humans in Group 3 or skeletal muscle from wild‐type, mdx52 or DMD‐null mice. Conclusions: Our results highlight the importance of considering expected effects of DMD mutations on dystrophin isoform production when considering patterns of DMD motor impairment and the implications for clinical practice and clinical trials. Our results suggest a complex relationship between dystrophin isoforms expressed in the brain and DMD motor function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, mutations occurring downstream of exon 63 in the DMD gene have also been associated with more rapid progression of motor impairment in individuals with DMD, indicating that the specific mutation location influences the severity and timing of functional decline (Chesshyre et al., 2022; Muntoni et al., 2023).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Chesshyre et al., 2022
In the citing paper
“By contrast, individuals with DMD, who lack all dystrophin isoforms, experience worse functional deficits than do those individuals who lack only isoforms Dp427 and Dp140 (Chesshyre et al., 2022).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Chesshyre et al., 2022
In the citing paper
“In individuals with DMD, similar correlations between the mutation site and motor function have been found in one (Chesshyre et al., 2022), but not in another (Thangarajh et al., 2021), study.”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Chesshyre et al., 2022
In the citing paper
“Although Dp140 is not expressed in muscle, mdx52 mice display more impaired executive motor function than do mdx/bl10 mice (Chesshyre et al., 2022).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Chesshyre et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765 · cited 1×
“31,32 Average four-limb grip strength in peak force at 3 months of age was 1.5 g/g lower in mdx52 D y s t r o p h i n i s o f o r m g r ou p i ng i n t h e a b o v e t a b l e i s a c c o r d i ng t o D M D m u t a t i on e x p e c t e d e ff e c t s on d y s t r o p h i n i s o f o r m e x p r e…”
InfluentialUljarević, M., Hedley, D., Alvares, G. A., Varcin, K. J., & Whitehouse, A. J. O. (2017) · Autism Research · doi:10.1002/aur.1763 · Cited by 42
Research works printed but not linked: 36
- Darras BT, 2015, Neuromuscular disorders of infancy, childhood, and adolescence: a clinician's approach
- 10.1016/S0140-6736(19)32910-1 · DOI · Paper page
- 10.1002/jcsm.12245 · DOI
- 10.1001/jamaneurol.2013.4908 · DOI
- 10.1172/JCI39845 · DOI · Paper page
- 10.1172/JCI37662 · DOI · Paper page
- 10.3390/jcm8050649 · DOI
- 10.1038/s41598-017-12981-5 · DOI · Paper page
- 10.1007/BF02265272 · DOI
- 10.1016/S1474-4422(03)00585-4 · DOI · Paper page
- 10.1042/bj2720557 · DOI · Paper page
- 10.1093/hmg/ddp320 · DOI
- 10.1038/sj.ejhg.5200488 · DOI
- 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y · DOI
- 10.1093/hmg/2.11.1877 · DOI
- 10.1111/dmcn.12922 · DOI · Paper page
- 10.1212/WNL.55.4.559 · DOI
- 10.1371/journal.pone.0008803 · DOI · Paper page
- 10.1136/jnnp-2012-303902 · DOI · Paper page
- 10.1371/journal.pone.0221097 · DOI
- 10.1002/pri.520 · DOI · Paper page
- 10.1002/ana.24222 · DOI · Paper page
- MareshK PapageorgiouA RidoutD HarrisonNA MandyW SkuseD et al.Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency. medRxiv [Internet].2021;2021.09.16.21263132. Available from:http://medrxiv.org/content/early/2021/09/22/2021.09.16.21263132.abstract
- 10.1016/j.chest.2020.03.021 · DOI
- 10.1111/dmcn.12620 · doi:10.1111/dmcn.12620
- 10.2307/2986270 · DOI · Paper page
- 10.1126/sciadv.abi8787 · DOI
- 10.1016/j.scr.2019.101688 · doi:10.1016/j.scr.2019.101688
- 10.1038/nprot.2015.057 · DOI
- Dubowitz V, 2020, Muscle biopsy a practial approach
- 10.1016/j.bbrc.2004.12.191 · DOI · Paper page
- 10.1006/bbrc.1997.7328 · DOI · Paper page
- Aartsma‐Rus A, 2014, Assessing functional performance in the mdx mouse model, J Vis Exp, 85
- 10.1093/oxfordjournals.jbchem.a124281 · DOI
- 10.1242/jcs.03000 · DOI
- 10.1016/j.nmd.2018.06.347 · doi:10.1016/j.nmd.2018.06.347
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Chesshyre, M., Ridout, D., Hashimoto, Y., Ookubo, Y., Torelli, S., Maresh, K., Ricotti, V., Abbott, L., Gupta, V. A., Main, M., Ferrari, G., Kowala, A., Lin, Y., Tedesco, F. S., Scoto, M., Baranello, G., Manzur, A., Aoki, Y., & Muntoni, F.
- Affiliations
- Dubowitz Neuromuscular Centre UCL Great Ormond Street Institute of Child Health London UK
- Population, Policy and Practice Research and Teaching Department UCL Great Ormond Street Institute of Child Health London UK
- Department of Molecular Therapy National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP) Kodaira Japan
- Department of Cell and Developmental Biology University College London London UK
- Centre for Genomics and Child Health, Blizard Institute, Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK
- ORCID
- Chesshyre, Mary
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2022-01-26
- Volume
- 13
- Issue
- 2
- Pages
- 1360-1372
- ISSN
- 2190-5991
- 2190-6009
- Cited by
- 66
- References
- 2
- Language
- en
- Funders
- National Institute on Handicapped Research (16NMDB‐DB60‐0004, CL‐2018‐18‐008)
- Muscular Dystrophy UK (RA4/3023/1)
- NIHR Great Ormond Street Hospital Biomedical Research Centre (759108, MGU0426, MR/K000608/1 (Institute of Neurology, University College London))
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.